Stockreport

Matinas BioPharma Regains Compliance with NYSE American Continued Listing Standards [Yahoo! Finance]

Matinas Biopharma Holdings, Inc.  (MTNB) 
NASDAQ:AMEX Investor Relations: ir.matinasbiopharma.com
PDF company focused on delivering groundbreaking therapies using its lipid nanocrystal (LNC) platform delivery technology, today announced that on March 21, 2024, the Compan [Read more]